Pharma-Bio Serv, Inc. (PBSV) Form 10-Q — Jun 15, 2026
Pharma-Bio Serv, Inc. reported its second fiscal quarter results for the period ended April 30, 2026, showing year-over-year revenue growth and improved profitability. Total revenue for the six months ended April 30, 2026, was approximately $5.0 million, an increase of approximately 2.2% compared to the same period last year. Net income for the six-month period was approximately $0.3 million, up from approximately $0.1 million in the prior year.
Key figures
- Eps
- 0.012
- Revenue
- 4997909
- Net Income
- 265846
- Total Debt
- 1045169
- Cash Position
- 1791474
- Revenue Growth
- 2.2%
- Cash dividend per share
- 0.075
- Shares repurchased six months
- 4300
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.